- Forums
- ASX - By Stock
- MSB
- Ann: FDA Grants Orphan Drug Designation for Revascor
Ann: FDA Grants Orphan Drug Designation for Revascor, page-65
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.40 |
Change
0.045(3.33%) |
Mkt cap ! $1.615B |
Open | High | Low | Value | Volume |
$1.35 | $1.42 | $1.33 | $3.802M | 2.753M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
3 | 38940 | $1.39 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.40 | 22571 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 657 | 1.540 |
1 | 977 | 1.480 |
8 | 25860 | 1.470 |
3 | 3101 | 1.440 |
1 | 59 | 1.435 |
Price($) | Vol. | No. |
---|---|---|
1.320 | 10000 | 1 |
1.330 | 4762 | 1 |
1.360 | 542 | 1 |
1.365 | 9 | 1 |
1.370 | 30000 | 1 |
Last trade - 16.10pm 08/11/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |
The Watchlist
EQN
EQUINOX RESOURCES LIMITED.
Zac Komur, MD & CEO
Zac Komur
MD & CEO
SPONSORED BY The Market Online